|
2021
|
Invention
|
Polypeptide derivative having dual receptor agonistic action and use thereof.
The present invent... |
|
|
Invention
|
Polypeptide derivative having dual receptor agonistic action and use thereof. The present inventi... |
|
2019
|
Invention
|
Glucagon-derived peptide and use thereof. Provided are a polypeptide derivative, modified derivat... |
|
|
Invention
|
Glucagon-derived peptide having dual receptor agonistic action and use thereof. Provided is a pol... |
|
|
Invention
|
2-oxo-1,2-dihydroquinoline derivatives, preparation method therefor, and pharmaceutical applicati... |
|
|
Invention
|
Pharmaceutical composition for treating diabetes, preparation method therefor, and use thereof. T... |
|
|
Invention
|
Crystal form of urate transporter 1 inhibitor and preparation method and use thereof. The present... |
|
2018
|
Invention
|
Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and... |
|
|
Invention
|
Thienopyridine derivative containing unsaturated fatty ethylenic bond and preparation method ther... |
|
2017
|
Invention
|
Method for preparing urate transporter 1 inhibitor. Provided is a method for preparing a URAT1 in... |
|
|
Invention
|
Method for preparing urate-anion exchanger 1 inhibitor. Provided is a method for preparing an URA... |
|
2016
|
Invention
|
Carboxylic acid urat1 inhibitor containing diarylmethane structure, preparation method and use th... |
